Key insights and market outlook
PT Bank Mandiri (Persero) Tbk (BMRI) has its share buyback plan approved until March 2026, with a maximum value of Rp1.17 trillion or 10% of total paid-up capital. The plan, approved during the Annual General Meeting of Shareholders (AGMS) on March 25, 2025, is expected to boost investor confidence and potentially increase stock value. As of Q3 2025, the buyback has not been executed, suggesting it may occur in Q4 2025 or Q1 2026.
PT Bank Mandiri (Persero) Tbk (BMRI), one of Indonesia's largest state-owned banks, has its share buyback plan approved until March 2026. The plan allows the company to repurchase shares worth up to Rp1.17 trillion, equivalent to 10% of its total paid-up capital. This corporate action was authorized during the Annual General Meeting of Shareholders (AGMS) held on March 25, 2025, and is expected to continue for a year until March 25, 2026.
Analysts believe that this share buyback plan can create value for investors by potentially increasing the stock's value. The buyback program is seen as a positive signal to the market, indicating the company's confidence in its financial health and future prospects. As of the third quarter of 2025, Bank Mandiri has not yet executed the share buyback, suggesting that the implementation is likely to occur in the fourth quarter of 2025 or the first quarter of 2026.
The decision to extend the buyback period demonstrates Bank Mandiri's commitment to strategic financial management and shareholder value enhancement. By repurchasing its shares, the bank aims to optimize its capital structure and potentially increase earnings per share (EPS). This move is particularly significant given the current market conditions and the bank's strong financial performance.
Share Buyback Plan Extension
AGMS Approval for Buyback
Potential Stock Value Increase